Welcome to LookChem.com Sign In|Join Free
  • or
Benzoic acid, 4-[[4-[4-[(tetrahydro-2H-pyran-4-yl)sulfonyl]phenyl]-2-pyrimidinyl]amino]- is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

434950-68-2

Post Buying Request

434950-68-2 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

434950-68-2 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 434950-68-2 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 4,3,4,9,5 and 0 respectively; the second part has 2 digits, 6 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 434950-68:
(8*4)+(7*3)+(6*4)+(5*9)+(4*5)+(3*0)+(2*6)+(1*8)=162
162 % 10 = 2
So 434950-68-2 is a valid CAS Registry Number.

434950-68-2Upstream product

434950-68-2Relevant academic research and scientific papers

Anilinopyrimidine derivatives as IKK inhibitors and compositions and methods related thereto

-

, (2008/06/13)

Compounds having activity as inhibitors of IKK are disclosed, particularly IKK-2. The compounds of this invention are anilinopyrimidine derivatives having the following structure: wherein R1 and R6 are as defined herein. Such compounds have utility in the treatment of a wide range of conditions that are responsive to IKK inhibition. Thus, methods of treating such conditions are also disclosed, as are pharmaceutical compositions containing one or more compounds of the above compounds.

Anilinopyrimidine derivatives as JNK pathway inhibitors and compositions and methods related thereto

-

, (2008/06/13)

Compounds having activity as inhibitors of the JNK pathway are disclosed. The compounds of this invention are anilinopyrimidine derivatives having the following structure: wherein R1 through R6 are as defined herein. Such compounds have utility in the treatment of a wide range of conditions that are responsive to inhibition of the JNK pathway. Thus, methods of treating such conditions are also disclosed, as are pharmaceutical compositions containing one or more compounds of the above compounds.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 434950-68-2